Jeffrey R Curtis1,2, Lang Chen3,4, Maria I Danila3,4, Kenneth G Saag3,4, Kathy L Parham3,4, John J Cush3,4. 1. From University of Alabama at Birmingham, Birmingham, Alabama; Baylor Research Institute, Dallas, Texas, USA. jrcurtis@uabmc.edu. 2. J.R. Curtis, MD, MPH, MS, University of Alabama at Birmingham; L. Chen, MD, PhD, University of Alabama at Birmingham; M.I. Danila, MD, MSc, MSPH, University of Alabama at Birmingham; K.G. Saag, MD, MSc, University of Alabama at Birmingham; K.L. Parham, BA, University of Alabama at Birmingham; J.J. Cush, MD, Baylor Research Institute. jrcurtis@uabmc.edu. 3. From University of Alabama at Birmingham, Birmingham, Alabama; Baylor Research Institute, Dallas, Texas, USA. 4. J.R. Curtis, MD, MPH, MS, University of Alabama at Birmingham; L. Chen, MD, PhD, University of Alabama at Birmingham; M.I. Danila, MD, MSc, MSPH, University of Alabama at Birmingham; K.G. Saag, MD, MSc, University of Alabama at Birmingham; K.L. Parham, BA, University of Alabama at Birmingham; J.J. Cush, MD, Baylor Research Institute.
Abstract
OBJECTIVE: The aim of our study was to examine why real-world practices and attitudes regarding quantitative measurements of rheumatoid arthritis (RA) have received limited attention. METHODS: An e-mail survey asked US rheumatologists to self-report on their use of quantitative measurements (metric). RESULTS: Among 439 respondents, metric rheumatologists (58%) were more likely to be in group practice and to use tumor necrosis factor inhibitors. The quantitative tools most commonly used were the Health Assessment Questionnaire (35.5%) and the Routine Assessment of Patient Index Data 3 (27.1%). Reasons for not measuring included time needed and electronic availability. Based on simulated case scenarios, providing more quantitative information increased the likelihood that a patient would change to a different disease-modifying antirheumatic drug or biologic. CONCLUSION: Routine use of quantitative measurement for patients in the United States with RA is increasing over time but remains low.
OBJECTIVE: The aim of our study was to examine why real-world practices and attitudes regarding quantitative measurements of rheumatoid arthritis (RA) have received limited attention. METHODS: An e-mail survey asked US rheumatologists to self-report on their use of quantitative measurements (metric). RESULTS: Among 439 respondents, metric rheumatologists (58%) were more likely to be in group practice and to use tumor necrosis factor inhibitors. The quantitative tools most commonly used were the Health Assessment Questionnaire (35.5%) and the Routine Assessment of Patient Index Data 3 (27.1%). Reasons for not measuring included time needed and electronic availability. Based on simulated case scenarios, providing more quantitative information increased the likelihood that a patient would change to a different disease-modifying antirheumatic drug or biologic. CONCLUSION: Routine use of quantitative measurement for patients in the United States with RA is increasing over time but remains low.
Authors: Jaclyn Anderson; Liron Caplan; Jinoos Yazdany; Mark L Robbins; Tuhina Neogi; Kaleb Michaud; Kenneth G Saag; James R O'Dell; Salahuddin Kazi Journal: Arthritis Care Res (Hoboken) Date: 2012-05 Impact factor: 4.794
Authors: Jasvinder A Singh; Kenneth G Saag; S Louis Bridges; Elie A Akl; Raveendhara R Bannuru; Matthew C Sullivan; Elizaveta Vaysbrot; Christine McNaughton; Mikala Osani; Robert H Shmerling; Jeffrey R Curtis; Daniel E Furst; Deborah Parks; Arthur Kavanaugh; James O'Dell; Charles King; Amye Leong; Eric L Matteson; John T Schousboe; Barbara Drevlow; Seth Ginsberg; James Grober; E William St Clair; Elizabeth Tindall; Amy S Miller; Timothy McAlindon Journal: Arthritis Rheumatol Date: 2015-11-06 Impact factor: 10.995
Authors: Josef S Smolen; Robert Landewé; Johannes Bijlsma; Gerd Burmester; Katerina Chatzidionysiou; Maxime Dougados; Jackie Nam; Sofia Ramiro; Marieke Voshaar; Ronald van Vollenhoven; Daniel Aletaha; Martin Aringer; Maarten Boers; Chris D Buckley; Frank Buttgereit; Vivian Bykerk; Mario Cardiel; Bernard Combe; Maurizio Cutolo; Yvonne van Eijk-Hustings; Paul Emery; Axel Finckh; Cem Gabay; Juan Gomez-Reino; Laure Gossec; Jacques-Eric Gottenberg; Johanna M W Hazes; Tom Huizinga; Meghna Jani; Dmitry Karateev; Marios Kouloumas; Tore Kvien; Zhanguo Li; Xavier Mariette; Iain McInnes; Eduardo Mysler; Peter Nash; Karel Pavelka; Gyula Poór; Christophe Richez; Piet van Riel; Andrea Rubbert-Roth; Kenneth Saag; Jose da Silva; Tanja Stamm; Tsutomu Takeuchi; René Westhovens; Maarten de Wit; Désirée van der Heijde Journal: Ann Rheum Dis Date: 2017-03-06 Impact factor: 19.103
Authors: Boulos Haraoui; Josef S Smolen; Daniel Aletaha; Ferdinand C Breedveld; Gerd Burmester; Catalin Codreanu; José Pereira Da Silva; Maarten de Wit; Maxime Dougados; Patrick Durez; Paul Emery; João Eurico Fonseca; Allan Gibofsky; Juan Gomez-Reino; Winfried Graninger; Vedat Hamuryudan; Maria José Jannaut Peña; Joachim Kalden; Tore K Kvien; Ieda Laurindo; Emilio Martin-Mola; Carlomaurizio Montecucco; Pedro Santos Moreno; Karel Pavelka; Gyula Poor; Mario H Cardiel; Ewa Stanislawska-Biernat; Tsutomu Takeuchi; Désirée van der Heijde Journal: Ann Rheum Dis Date: 2011-07-29 Impact factor: 19.103
Authors: Ceara Tess Cunningham; Hude Quan; Brenda Hemmelgarn; Tom Noseworthy; Cynthia A Beck; Elijah Dixon; Susan Samuel; William A Ghali; Lindsay L Sykes; Nathalie Jetté Journal: BMC Med Res Methodol Date: 2015-04-09 Impact factor: 4.615
Authors: Michael M Ward; Isabel Castrejon; Martin J Bergman; Maria I Alba; Lori C Guthrie; Theodore Pincus Journal: J Rheumatol Date: 2018-10-15 Impact factor: 4.666
Authors: Carson Maynard; Ted R Mikuls; Grant W Cannon; Bryant R England; Philip G Conaghan; Mikkel Østergaard; Daniel G Baker; Gail Kerr; Michael D George; Jennifer L Barton; Joshua F Baker Journal: Arthritis Care Res (Hoboken) Date: 2020-03 Impact factor: 4.794
Authors: Justin K Owensby; Lang Chen; Ronan O'Beirne; Eric M Ruderman; Leslie R Harrold; Joshua A Melnick; Monika M Safford; Jeffrey R Curtis; Maria I Danila Journal: Arthritis Care Res (Hoboken) Date: 2020-07 Impact factor: 4.794
Authors: Jeffrey R Curtis; Fenglong Xie; Shuo Yang; Maria I Danila; Justin K Owensby; Lang Chen Journal: J Rheumatol Date: 2018-11-15 Impact factor: 4.666
Authors: Michaela Koehm; Matthew J McIntosh; Michael W Hofmann; Varghese Abraham; Cem Gabay; Ernest H Choy; Arthur Kavanaugh; Harald Burkhardt; Frank Behrens Journal: Rheumatol Int Date: 2020-02-10 Impact factor: 2.631